Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VPSCRO (Venturepharm Clinical Research Organization) is a full-service contract research organization (CRO) based in Beijing, China, and a subsidiary of China Health Group Inc. (formerly Venturepharm Laboratories). Established as a Sino-Canadian-American joint venture, VPSCRO provides a comprehensive suite of clinical development services, including Phase I-IV clinical trials, regulatory affairs, data management, and biostatistics. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system (CNS) disorders, and respiratory conditions. VPSCRO has a significant track record in the Chinese market, having completed over 100 clinical trials and maintained strategic alliances with international partners like Suven Life Sciences to support global drug development in Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VPSCRO.